Want to see RNAZ full AI Analyst Report?
TransCode Therapeutics (RNAZ) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ttx-Mc138 | Advanced Solid Tumor | phase1AndPhase2 | Active Not Recruiting | Study of TTX-MC138 in Subjects With Advanced Solid Tumors | Dec 12, 2023 | ― |
| Ttx-Mc138-Nodaga-Cu64 | Advanced Solid Tumor | earlyPhase1 | Completed | A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors | May 26, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ttx-Mc138 | phase1AndPhase2 | Advanced Solid Tumor | Active Not Recruiting | Study of TTX-MC138 in Subjects With Advanced Solid Tumors | Dec 12, 2023 | ― |
| Ttx-Mc138-Nodaga-Cu64 | earlyPhase1 | Advanced Solid Tumor | Completed | A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors | May 26, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Transcode Therapeutics, Inc. (RNAZ) have in its pipeline
TransCode Therapeutics RNAZ is currently developing the following drugs: Ttx-Mc138, Ttx-Mc138-Nodaga-Cu64. These drug candidates are in various stages of clinical development as the company works toward FDA approval.